Both in Pharmaceuticals
GT Biopharma vs Moleculin Biotech
Over the past year GTBP returned −66.9% and MBRX returned −96.4%; their daily moves had a correlation of -0.02.
GTBP −66.9% MBRX −96.4%Growth of $1, one year, split-adjusted
| Metric | GTBP | MBRX |
|---|---|---|
| Price | $5.51 | $8.75 |
| Market cap | $9.9M | $8.9M |
| Today | −1.25% | −5.61% |
| 1 month | −19.9% | −16.9% |
| 6 months | −19.0% | −82.6% |
| Year to date | −71.9% | −86.8% |
| 1 year | −68.3% | −96.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 958.3% | 850.7% |
| Short % of float | 24.1% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).